+ Chinese + English

首页关于格然林 | 新闻中心 | 服务与产品 | 文献知识库 | 基础设施 | 企业文化与人才 | 联系我们 |

药物开发服务

产品与服务信息

Carbohydrate Derivatives

Nucleosides and Reagents

Super-chelating Agents & MRI Contrast Agents

Heterocyclic Compounds

Intermediate & Building Blocks

Formulation Products and Drugs substances

Flavoring, Additives and Agricultural Products

Fire Retardants

Metal complexes

Bio-reagents and conjugation reagents

0371-6711 0368

Nucleosides and Reagents

首页 > 服务与产品 > Nucleosides and Reagents > Halo-nucleosides

GL100563 POST:2013-06-02
GL100484 POST:2013-06-02
GL100403 POST:2013-05-31
GL100551 POST:2013-05-31
GL100539 POST:2013-05-31
GL100532 POST:2013-05-31
GL100529 POST:2013-05-31
GL100525 POST:2013-05-31
GL100520 POST:2013-05-31
GL100519 POST:2013-05-31
GL100472 POST:2013-05-31
GL100482 POST:2013-05-31
GL100451 POST:2013-05-31
GL100432 POST:2013-05-31
GL100431 POST:2013-05-31
GL100393 POST:2012-11-13
GL100392 POST:2012-11-13
GL100391 POST:2012-11-13
GL100380 POST:2012-11-13
GL100379 POST:2012-11-13
GL100324 POST:2012-06-09
GL100265 POST:2012-05-13
GL100250 POST:2012-05-13
GL100249 POST:2012-05-13
GL100180 POST:2012-05-12
GL100244 POST:2012-05-12
GL100243 POST:2012-05-12
GL100184 POST:2012-05-12
GL100183 POST:2012-05-12
GL100308 POST:2012-05-12
GL100307 POST:2012-05-12
GL100266 POST:2012-05-12

CurrentPage:2/3 [1] [2] [3]

: 关于格然林 | 新闻中心 | 服务与产品 | 文献知识库 | 基础设施 | 企业文化与人才 | 联系我们 |

© 1998 - 2022 Granlen Inc. 保留所有权利豫ICP备19022032号-1